Showing 1 - 10 of 21,066
innovation. This sentiment stems, in large part, from the belief that pharmaceutical research and development (R&D) entails …
Persistent link: https://www.econbiz.de/10014161723
largely based on Open Innovation. For that purpose, exploratory case studies will be shown that exemplify the value of … implementing Open Innovation in the pandemic context. These case studies concern the pharmaceutical firm Pfizer, the biotechnology … systematic analysis of articles, scientific documents, and published reports related to the Open Innovation involvement of these …
Persistent link: https://www.econbiz.de/10014308369
neglected diseases. A number of alternative innovation incentives have therefore been proposed. This paper highlights some of …
Persistent link: https://www.econbiz.de/10014132514
Persistent link: https://www.econbiz.de/10013170079
This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of successful research projects. We provide clear evidence that externally sourced projects and projects involving biotechnologies perform better than internal projects and chemical...
Persistent link: https://www.econbiz.de/10011374419
Persistent link: https://www.econbiz.de/10003915982
Persistent link: https://www.econbiz.de/10010494939
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a...
Persistent link: https://www.econbiz.de/10011406575
Persistent link: https://www.econbiz.de/10012513155
Persistent link: https://www.econbiz.de/10011589125